Workup and Diagnosis of Low IgG and Low IgM

Initial Confirmatory Testing

Repeat serum IgG and IgM measurements at least one month apart to verify persistent deficiency, recognizing that transient hypogammaglobulinemia is common and usually does not require aggressive therapy. [1][2]
Measure serum total protein and albumin to detect secondary hypogammaglobulinemia due to protein loss conditions such as nephrotic syndrome or protein‑losing enteropathy. [1][3]
Obtain a serum IgA level; a normal or low IgA together with low IgG/IgM helps differentiate among diagnostic categories. 1

Evaluate vaccine‑induced protein antibody responses (e.g., tetanus, diphtheria) as a primary method to distinguish clinically significant immunodeficiency from benign hypogammaglobulinemia. 1
Assess polysaccharide antibody responses after pneumococcal vaccination (Pneumovax‑23 for patients > 6 years):

Perform flow‑cytometric enumeration of total B cells and subsets, emphasizing switched memory B cells (CD27⁺ IgD⁻). 1
An absent or markedly low B‑cell proportion (< 2 %) suggests agammaglobulinemia or severe CVID. 1
Most CVID patients exhibit normal B‑cell counts but impaired functional responses. 1

Review current and recent medications; anti‑epileptic agents such as phenytoin, carbamazepine, and valproic acid can cause secondary immunodeficiency. 4
Rituximab (anti‑CD20) is a recognized cause of drug‑induced hypogammaglobulinemia. 2
Additional agents associated with secondary immunodeficiency include sulfasalazine, gold salts, penicillamine, hydroxychloroquine, and NSAIDs. 4
Thoraco‑abdominal CT scanning is recommended to identify thymoma (Good syndrome), lymphoma, splenomegaly, or lymphadenopathy that may underlie secondary hypogammaglobulinemia. 4

In cases of marked humoral deficiency (very low IgG and IgM), assess lymphocyte subsets (CD3, CD4, CD8, CD19, CD16/56) to identify combined immunodeficiency, which carries a poorer prognosis. 1

A positive family history is present in approximately 20–25 % of patients with CVID or other antibody deficiencies. 4
Do not establish a primary immunodeficiency diagnosis based on a single low immunoglobulin result; persistence must be confirmed. [2][5]
Medication‑induced hypogammaglobulinemia should be considered, as it is often reversible upon drug discontinuation. 4
Prompt evaluation of cellular immunity is essential when severe hypogammaglobulinemia is identified, to guide appropriate management. 1
Ongoing surveillance for malignancy and lymphoproliferative disorders is recommended in patients diagnosed with CVID. 4

Measure serum total protein and albumin to rule out secondary hypogammaglobulinemia from protein‑losing conditions (e.g., nephrotic syndrome, protein‑losing enteropathy, lymphatic disorders)【6】.
Verify that the IgA level is truly normal for the patient’s age, because the combination of low IgG/IgM with normal IgA is uncommon and does not meet classic CVID criteria【7】.

Do not start immunoglobulin replacement therapy solely on low IgG/IgM values; therapy should be reserved for patients with documented impaired vaccine responses and recurrent infections that affect quality of life【7】.
For patients with recurrent sinopulmonary infections, consider aggressive antimicrobial therapy and prophylaxis【8】.

Most patients with CVID have normal total B‑cell counts despite functional impairment, whereas agammaglobulinemia is characterized by absent or markedly reduced B cells (<2%)【6】.

Review all current and recent medications because drug‑induced hypogammaglobulinemia is often reversible after discontinuation【8】.
Medications known to cause hypogammaglobulinemia include anti‑epileptic drugs (phenytoin, carbamazepine, valproic acid, zonisamide), rituximab (anti‑CD20), sulfasalazine, gold salts, penicillamine, hydroxychloroquine, and NSAIDs【8】.

In children younger than 4 years, avoid diagnosing CVID; transient hypogammaglobulinemia of infancy is common and usually resolves spontaneously【7】.
Age‑related transient hypogammaglobulinemia in young children often normalizes without intervention【7】.

Classic CVID typically presents with low IgG and low IgA (IgM may be normal or low); a pattern of low IgG/IgM with normal IgA is atypical for CVID【7】.

The most frequent pathogens in antibody‑deficient patients are encapsulated bacteria such as Haemophilus influenzae and Streptococcus pneumoniae, as well as atypical organisms like Mycoplasma spp. and Ureaplasma spp【7】.